Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Project Sage Oldco Inc SIENQ

Healthcare Medical Instruments & Supplies
Project Sage Oldco Inc., formerly Sientra, Inc., is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by... see more

Recent & Breaking News (PINL:SIENQ)

Sientra Reports Record Third Quarter 2022 Financial Results

GlobeNewswire November 10, 2022

Sientra to Report Third Quarter 2022 Financial Results on November 10, 2022

GlobeNewswire October 31, 2022

Sientra Announces Pricing of $13.2 Million Public Offering

GlobeNewswire October 21, 2022

Sientra Announces Proposed Public Offering

GlobeNewswire October 18, 2022

Sientra Announces Preliminary Unaudited Third Quarter Financial Results and Signing of Senior Secured Loan Facilities With Deerfield Management

GlobeNewswire October 12, 2022

Sientra Supports Breast Cancer Awareness Month by Launching Educational Programs Designed to Empower Women

GlobeNewswire October 3, 2022

Sientra Receives Regulatory Approval to Market Breast Implants in Saudi Arabia

GlobeNewswire September 20, 2022

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire September 6, 2022

Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel

GlobeNewswire August 11, 2022

Sientra to Report Second Quarter 2022 Financial Results on August 11, 2022

GlobeNewswire July 28, 2022

Sientra Wins Premier's Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value Creation

GlobeNewswire July 11, 2022

FDA Approves Sientra's Low Plus Profile Projection Breast Implant

GlobeNewswire July 6, 2022

Sientra To Present At The William Blair 42nd Annual Growth Stock Conference

GlobeNewswire May 23, 2022

Sientra To Participate At The 19th Annual Craig-Hallum Institutional Investor Conference

GlobeNewswire May 18, 2022

Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022

GlobeNewswire May 12, 2022

Sientra to Report First Quarter 2022 Financial Results on May 12, 2022

GlobeNewswire May 3, 2022

Sientra to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT

GlobeNewswire March 24, 2022

Sientra Receives Regulatory Approval to Market Breast Implants in Canada

GlobeNewswire March 24, 2022

Sientra Reports Record Plastic Surgery Revenue for Both Fourth Quarter and Full Year 2021

GlobeNewswire March 23, 2022

Sientra to Report Fourth Quarter and Full Year 2021 Financial Results on March 23, 2022

GlobeNewswire March 9, 2022